The medical research industry is at the forefront of innovation and can experience significant growth fueled by rising health awareness, an aging population, and technological advancements. Moreover, the healthcare sector tends to be relatively resilient, as the demand for medical products and services remains relatively stable regardless of economic conditions.
Given the backdrop, it could be wise to scoop up the shares of three fundamentally sound stocks, Laboratory Corporation of America Holdings (LH), Qiagen N.V. (QGEN), and Lantheus Holdings, Inc. (LNTH), which seem well positioned to capitalize on the industry’s growth prospects.
